Form 8-K - Current report:
SEC Accession No. 0001140361-24-043979
Filing Date
2024-10-23
Accepted
2024-10-23 08:10:06
Documents
19
Period of Report
2024-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20037482x1_8k.htm   iXBRL 8-K 84363
2 EXHIBIT 2.1 ny20037482x1_ex2-1.htm EX-2.1 526406
3 EXHIBIT 10.1 ny20037482x1_ex10-1.htm EX-10.1 128378
4 EXHIBIT 10.2 ny20037482x1_ex10-2.htm EX-10.2 59767
5 EXHIBIT 10.3 ny20037482x1_ex10-3.htm EX-10.3 117137
6 EXHIBIT 99.1 ny20037482x1_ex99-1.htm EX-99.1 20828
10 ny20037482x1_ex99-1img01.jpg GRAPHIC 14518
  Complete submission text file 0001140361-24-043979.txt   1309033

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lumo-20241022.xsd EX-101.SCH 3877
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lumo-20241022_lab.xml EX-101.LAB 21966
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lumo-20241022_pre.xml EX-101.PRE 16052
21 EXTRACTED XBRL INSTANCE DOCUMENT ny20037482x1_8k_htm.xml XML 4194
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

EIN.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 241387842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)